Capstone Therapeutics Corp. (CAPS)
(Delayed Data from NSDQ)
$1.18 USD
-0.17 (-12.59%)
Updated Oct 15, 2025 04:00 PM ET
After-Market: $1.18 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Capstone Therapeutics Corp. has a market cap of $9.84M, which represents its share price of $1.35 multiplied by its outstanding shares number of 7.29M. As a small-cap company, CAPS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CAPS 1.18 -0.17(-12.59%)
Will CAPS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CAPS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAPS
Crossed Above 20 Day Moving Average appears for CAPS after 20.54% move
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
Is CAPS primed for volatility? NR7 shows up after dropping 0.88%
Capstone Holding (CAPS) Achieves Early Success Post-Carolina Stone Integration
Capstone Therapeutics achieves milestones in Carolina Stone integration